Alvaro
Lassaletta Atienza
Consultor Médico
![Foto de Alvaro](/img/nophoto.png)
![Foto de Osaka City General Hospital](/img/noimage_org.png)
Osaka City General Hospital
Osaka, JapónOsaka City General Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600 Mutant Pediatric High-Grade Glioma
Journal of Clinical Oncology, Vol. 41, Núm. 33, pp. 5174-5183